Vr Adviser, LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Vr Adviser, LLC
- $658 Million
- Q3 2025
A detailed history of Vr Adviser, LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 6,728,985 shares of KALV stock, worth $89.6 Million. This represents 12.35% of its overall portfolio holdings.
Number of Shares
6,728,985
Previous 6,728,985
-0.0%
Holding current value
$89.6 Million
Previous $76.1 Million
6.81%
% of portfolio
12.35%
Previous 15.07%
Shares
5 transactions
Others Institutions Holding KALV
# of Institutions
155Shares Held
57.9MCall Options Held
1.21MPut Options Held
865K-
Tang Capital Management LLC San Diego, CA5.04MShares$67.2 Million2.77% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.04MShares$67.1 Million2.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.77MShares$63.5 Million1.73% of portfolio
-
Capital World Investors Los Angeles, CA3.18MShares$42.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.95MShares$39.2 Million0.0% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $328M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...